Thu, Jul 24, 2014, 2:06 PM EDT - U.S. Markets close in 1 hr 54 mins

Recent

% | $
Click the to save as a favorite.

Cleveland BioLabs, Inc. Message Board

  • fpmiike fpmiike Oct 2, 2013 9:43 AM Flag

    Good News / Bad News

    Good news is immediate cash issue has been addressed and FDA and BARDA discussions are still alive based on the terms of the loan. Also, good that someone has underwritten the risk and determined it credit worthy. Bad news is it seems like there has been yet another delay (no FDA agreement or BARDA award) based on stock price and the timing of this loan. Delay will likely be compounded while the children squabble in DC so the wait continues.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'll admit i was so much more concerned with how the financing was going to be addressed, then whether they'd get BARDA funding by sept 30. Based on last Q's stated cash burn, Biolabs only had enough money to last through the first week in january, now, with the $6M, they're good through mid May. If they had HAD to do a secondary..... pricing would probably have been $1.25ish & the stock would be trading now at just a little over $1, not to mention the additional dillution from repricing all the friggin' warrants. I'm a little surprised that at the last minute, debt was even available to them......nicely done.

      Sentiment: Buy

 
CBLI
0.46-0.01(-2.52%)1:47 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.